Ocular Therapeutix, Inc. (OCUL)
NASDAQ·Healthcare·Biotechnology
$7.27
+8.11%
Mkt Cap $1.43B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (14 analysts)
$27.50
Range $25.00 – $30.00
Implied Upside
+278.5%
Consensus $27.50 vs current $7.27
NASDAQ·Healthcare·Biotechnology
$7.27
+8.11%
Mkt Cap $1.43B
Buy
11
Hold
0
Sell
0
Price Target (14 analysts)
$27.50
Range $25.00 – $30.00
+278.5%
Consensus $27.50 vs current $7.27